Our results demonstrated a frequency of 1.67% (1/60) of the CYP21A2 genomic variant IVS2-13A/C>G in the group of consecutively recruited adult Eastern European PCOS patients diagnosed by the Rotterdam criteria. The gene discussed is CYP21A2; the disease is polycystic ovary syndrome.